Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details Textual)

v3.5.0.2
Stockholders' Equity (Details Textual) - USD ($)
 1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Mar. 17, 2016
Feb. 23, 2016
May 31, 2015
Mar. 31, 2015
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Dec. 31, 2015
Mar. 17, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Common Stock, Shares Authorized         50,000,000   50,000,000   50,000,000  
Common Stock, Par or Stated Value Per Share         $ 0.0001   $ 0.0001   $ 0.0001  
Common Stock, Shares, Issued         17,045,876   17,045,876   15,989,315  
Common Stock, Shares, Outstanding         17,045,876   17,045,876   15,989,315  
Share-based Compensation             $ 2,651,000 $ 2,084,000    
Equity Method Investment ,Annual Equity Fee,Percentage                   2.50%
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options         $ 4,500,000   $ 4,500,000      
2015 Incentive Plan [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant         762,000   762,000      
Restricted Stock [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number         2,222,375   2,222,375   2,500,000  
Restricted Stock [Member] | Market Approach Valuation Method [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Weighted Market Value Percentage Of Invested Capital       44.80%            
Weighted Average Cost Percentage Of Capital       30.00%            
Share Price       $ 0.065 $ 4.42   $ 4.42   $ 4.39  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate             83.00%   83.00%  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate             1.35%   1.50%  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term             5 years   5 years  
Non-vested Resricted Stock [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition             1 year 11 months 23 days      
Performance Shares [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number         333,334   333,334      
Dr. Marasco [Member] | Share-based Compensation Award, Tranche One [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period       48 months            
Percentage of award vested on first anniversary date     25.00%              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross       1.5            
General and Administrative Expense [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Share-based Compensation         $ 300,000   $ 1,000,000      
Research and Development Expense [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Share-based Compensation         20,000   20,000      
Research and Development Expense [Member] | Grant [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Share-based Compensation         $ 400,000 $ 2,100,000 1,600,000 $ 2,100,000    
Opus Point Healthcare Fund GP, LLC [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Proceeds from Issuance of Private Placement   $ 600,000                
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right   3,500                
Class of Warrant or Right, Exercise Price of Warrants or Rights   $ 7.00                
Class Of warrant Or Right ,Warrant Term   5 years                
Stock Issued During Period, Shares, New Issues   126,640                
Sale of Stock, Number of Shares Issued in Transaction   10,000                
Sale of Stock, Consideration Received on Transaction   $ 45,000                
Fortress Biotech, Inc [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Stock Issued During Period, Shares, New Issues 688,755 3,166                
Share-based Compensation             $ 14,000      
Equity Method Investment ,Annual Equity Fee,Percentage 2.50% 2.50%                
Common Class A [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Common Stock, Shares Authorized         15,000,000   15,000,000      
Common Stock, Shares, Issued         7,000,000   7,000,000   7,000,000  
Common Stock, Shares, Outstanding         7,000,000   7,000,000   7,000,000  
Common Stock, Voting Rights             number of votes per share equal to 1.1 times a fraction      
Stock Issued During Period, Shares, New Issues             0      
Unregistred Common Stock [Member] | Opus Point Healthcare Fund GP, LLC [Member] | General and Administrative Expense [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Number Of Warrant Issued   44,324